THNR dividend overview
Amplify Weight Loss Drug & Treatment ETF is tracked by Yieldly as a dividend-paying security in United States. Its trailing 12-month dividend yield is 1.53%, calculated from recorded dividends and a reference price of $26.97.
The recorded annual dividend is $0.41, with a reported payment frequency of Annual. Yield changes when the share price or dividend changes, so it should be considered alongside payout coverage, dividend consistency, and the underlying business.
Latest recorded THNR dividend
| Declaration date | |
|---|---|
| Ex-dividend date | |
| Record date | |
| Payment date | |
| Dividend amount | $0.4132 |
THNR dividend history
The table shows up to 12 of the most recent recorded and announced distributions from the past five years. Dividend amounts are shown per share in the listed currency.
| Ex-dividend date | Payment date | Amount | Frequency | Status |
|---|---|---|---|---|
| $0.4132 | Annual | Historical | ||
| $0.2199 | Annual | Historical |
Company and dividend details
| Ticker | THNR |
|---|---|
| Company or fund | Amplify Weight Loss Drug & Treatment ETF |
| Market | United States |
| Categories | ETFs |
| Market capitalization | $4.6M |
| Trailing 12-month observations | — |
| History rows shown | 2 |
| Snapshot date | September 3, 2026 |
How to interpret THNR's dividend yield
Trailing yield uses dividends recorded during the previous 12 months divided by the reference share price. It describes past distributions relative to price; it does not guarantee the next dividend. A rising yield may reflect a dividend increase, a falling share price, or both.
Before making an investment decision, review the complete payment history, payout coverage, dividend announcements, and the company's financial condition. Learn how dividend yield is calculated and how ex-dividend and payment dates work.